An Immunoregulatory Role of Interleukin-3 in Allergic Asthma.

Front Immunol · 2022 · PMC8904351 · PMID 35281014

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In addition, mice treated with rIL-3 showed a trend to reduction of lung inflammation ( Supplementary Figures 2B, C ) and significant reduction of mucus production ( Figures 2B, C ) but no change in serum IgE levels ( Figure 2D ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.